Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 17 May 2006. doi:10.1136/ard.2005.051292
Annals of the Rheumatic Diseases 2006;65:1490-1494
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2005.051292v1
65/11/1490    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersson, M L E
Right arrow Articles by Saxne, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, M L E
Right arrow Articles by Saxne, T

EXTENDED REPORT

Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis

M L E Andersson 1, I F Petersson 1, K E Karlsson 3, E N Jonsson 3, B Månsson 2, D Heinegård 4, T Saxne 2

1 Spenshult’s Hospital for Rheumatic Diseases, Halmstad, Sweden
2 Department of Rheumatology, Lund University, Lund, Sweden
3 Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
4 Department of Experimental Medical Science, Section for Cell and Matrix Biology, Lund University

Correspondence to:
Correspondence to:
M Andersson
Spenshult’s Hospital for Rheumatic Diseases, SE-313 92 Oskarström, Sweden; maria.andersson{at}spenshult.se

Objective: To monitor changes in serum concentrations of cartilage oligomeric matrix protein (COMP) during a 24-h period to determine any diurnal variation, and to estimate the half life of COMP in the circulation in patients with symptomatic knee osteoarthritis and in those with rheumatoid arthritis.

Methods: Serum samples were drawn every 4 h (7 samples/patient over 24 h) in 10 patients with knee osteoarthritis and 14 patients with rheumatoid arthritis. Osteoarthritis was defined radiographically and clinically (American College of Rheumatology (ACR) criteria) and rheumatoid arthritis according to the 1987 ACR criteria. Serum COMP was measured by sandwich ELISA. A statistical model for the diurnal variation in the COMP levels was developed using the computer program NONMEM.

Results: No considerable changes in COMP levels were observed during the day between 08:00 and 21:00 in either group. A significant decrease in serum COMP was apparent during bed rest at night, reaching the lowest levels between 04:00 and 05:00 (p<0.03 or better v all other time points) in patients with osteoarthritis and in those with rheumatoid arthritis. From the rate of decreasing serum COMP levels, a putative half life of COMP in the circulation was estimated to be 7.4 h.

Conclusion: During normal daytime activities, serum COMP levels are constant. The decrease during the night indicates a rapid elimination of COMP once it has reached the circulation. The stable COMP levels during the day suggest that it is not necessary to further standardise the time of serum sampling in clinical practice.


Abbreviations: ACR, American College of Rheumatology; COMP, cartilage oligomeric matrix protein; DMARD, disease-modifying antirheumatic drug




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
G. MOROZZI, M. FABBRONI, F. BELLISAI, G. PUCCI, and M. GALEAZZI
Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases: Potential Use as a Marker for Measuring Articular Cartilage Damage and/or the Therapeutic Efficacy of Treatments
Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 398 - 407.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
F. V. von Steyern, I. Kristiansson, K. Jonsson, P. Mannfolk, D. Heinegard, and A. Rydholm
Giant-cell tumour of the knee: THE CONDITION OF THE CARTILAGE AFTER TREATMENT BY CURETTAGE AND CEMENTING
J Bone Joint Surg Br, March 1, 2007; 89-B(3): 361 - 365.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism